结直肠癌中的KRAS突变:对瘤微环境的影响和治疗含义
Anita Emami1, Pouya Mahdavi Sharif1, Nima Rezaei1,2,3
1Tehran University of Medical Sciences, Tehran, Iran.
Expert opinion on therapeutic targets
|May 5, 2025
概括
针对结直肠癌 (CRC) 中的KRAS突变对新疗法至关重要. 正在制定新的策略,以克服挑战并改善晚期CRC患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 结肠直肠癌 (CRC) 仍然是癌症死亡的重要原因,尽管发病率下降.
- 虽然免疫疗法和向疗法是有前途的,但许多CRC患者,尤其是晚期疾病患者,的治疗结果并不理想.
- KRAS突变在CRC中普遍存在,并驱动瘤的进展,转移和对治疗的抗性.
研究的目的:
- 讨论KRAS突变对结直肠癌瘤微环境的影响.
- 探索针对KRAS信号通路和抵抗机制的新型治疗策略.
- 突出开发抗KRAS突变药物的挑战和潜力.
主要方法:
- 关于结直肠癌中KRAS突变的当前文献的综述.
- 分析KRAS在瘤微环境调节中的作用.
- 讨论新兴的治疗策略,包括组合疗法.
主要成果:
- 在CRC中,KRAS突变极大地影响瘤微环境和治疗反应.
- 开发针对KRAS的药物是具有挑战性的,因为它的结构和基本功能.
- 临床前和早期临床数据表明,将KRAS抑制剂与其他疗法结合起来是有前途的.
结论:
- 对于晚期结直肠癌的新疗法,特别是针对KRAS突变的新疗法,存在重大未满足的需求.
- 克服耐药性和有效地针对KRAS需要创新的策略.
- 将KRAS抑制剂与免疫疗法和向疗法结合起来,有望改善CRC患者的治疗结果.
更多相关视频
06:19Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer
Published on: July 18, 2017
9.9K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.5K
相关概念视频
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.2K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
